Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1999
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051747A1 Gene encoding desulfurases
10/14/1999WO1999051746A1 Improved yeast strain
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051743A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051740A2 Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
10/14/1999WO1999051739A1 Protein variant of the net1 locus
10/14/1999WO1999051738A1 Human gap junction protein beta-4
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
10/14/1999WO1999051734A1 Glass microfiber column and method for the preparation and purification of plasmid dna using the same
10/14/1999WO1999051733A2 Enterotoxin-deficient bacillus
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051731A2 Maize histone deacetylases and their use
10/14/1999WO1999051730A2 Mammalian gene encoding tolloid-like protein
10/14/1999WO1999051729A1 Pentaerythritol lipid derivatives
10/14/1999WO1999051728A2 Control of floral induction in plants and uses therefor
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051724A1 PURIFICATION OF HUMAN ACID α-GLUCOSIDASE
10/14/1999WO1999051723A2 Bacterial transglutaminases
10/14/1999WO1999051722A2 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same
10/14/1999WO1999051721A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
10/14/1999WO1999051643A1 Mutagenized il13-based chimeric molecules
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051641A1 G-protein fusion receptors and chimeric gabab receptors
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051636A2 Gaba b receptor
10/14/1999WO1999051634A1 Human gap junction protein beta-3
10/14/1999WO1999051633A1 Proteins having immunomodulatory activity and remedies for immunological diseases
10/14/1999WO1999051632A1 Circularly permuted biotin binding proteins
10/14/1999WO1999051630A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999WO1999051629A2 New compounds for dna-transfection
10/14/1999WO1999051625A2 Peptides causing formation of compact structures
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051621A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/14/1999WO1999051581A1 Novel nucleic acid transfer agents, compositions containing same and uses
10/14/1999WO1999051274A1 Polyene macrolide derivatives, use for vectoring molecules
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051265A1 Nucleic acid encoding hyaluronan synthase and methods of use
10/14/1999WO1999051264A2 Leishmania cysteine proteinases
10/14/1999WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051206A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999043819B1 Family of maize pr-1 genes and promoters
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999043705A8 N-terminally truncated glp-1 derivatives
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999WO1999041399A9 Methods for purified aav vector production
10/14/1999WO1999041394A9 Nucleotide sequences encoding maize rad51
10/14/1999WO1999040221A3 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999WO1999037803A3 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
10/14/1999WO1999037783A9 Live vaccine against brucellosis
10/14/1999WO1999037681A3 Method for producing antibody fragments
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
10/14/1999WO1999036556A3 Process for the production of alanine by recombinant microorganisms
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999033999A9 Mitogen-activated protein kinase kinase 7 (mkk7)
10/14/1999WO1999033980A9 Members of tnf and tnfr families
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999WO1999022773A3 Sequences for targeting metastatic cells
10/14/1999WO1999019488A8 Novel human egf receptors and use thereof
10/14/1999WO1999010486A3 Mdm2-specific antisense oligonucleotides
10/14/1999DE19913741A1 New Arthrobacter aurescens recombinant L-N-carbamoylase, useful for production of amino acids
10/14/1999DE19816129A1 T-Zellrezeptor-Expressionskassette T-cell receptor expression cassette
10/14/1999DE19816116A1 Preparation of conditionally immortalized immortalization-helper cells, used to immortalize mammalian cells, e.g. for production of hybridomas
10/14/1999DE19815685A1 Recombinant Rhodobacter sphaeroides 3-hydroxy fatty acid dehydrogenase gene and methods of production
10/14/1999DE19806431C1 Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen New method for identification and characterization of mRNA molecules
10/14/1999CA2577543A1 Antibody variants and fragments thereof
10/14/1999CA2329135A1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/14/1999CA2328294A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999CA2327737A1 Polyene macrolide derivatives, use for vectoring molecules
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2327445A1 Recombinant potyvirus construct and use thereof
10/14/1999CA2327400A1 Directed evolution biosensors
10/14/1999CA2327367A1 New compounds for dna-transfection
10/14/1999CA2326835A1 A method for obtaining a plant with a genetic lesion in a gene sequence
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999CA2326130A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999CA2326066A1 A interleukin-1 receptor antagonist and uses thereof
10/14/1999CA2325849A1 Pentaerythritol lipid derivatives
10/14/1999CA2325571A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325352A1 Control of floral induction in plants and uses therefor
10/14/1999CA2325346A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999CA2325341A1 Mutagenized il13-based chimeric molecules
1 ... 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 ... 4023